Name
DiscGenics
What We Do
DiscGenics is developing IDCT, a single-injection cell therapy to treat lumbar disc degeneration. With successful Phase I/II trials and FDA RMAT/Fast Track status, the company is advancing to Phase III and broadening its regenerative platform.
Website
Address
5940 Harold Gatty Drive
84116
84116